The future looks bleak for a big anti-malaria project you may not have heard of — the AMFm, Affordable Medicines Facility for malaria.
The idea of the $463-million AMFm, launched in 2004, was to subsidize the supply of anti-malaria drugs so that people in poor countries could afford the life-saving medications. People did get them, and malaria rates have declined significantly since. But as Nature reports, experts are raising concerns about this particular initiative due to lack of clear evidence that it had much impact.
So the push is on to either significantly alter the AMFm initiative or just kill it.
But let’s try to keep in mind that old axiom – “Absence of Evidence is not Evidence of Absence.” Continue reading